Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Accenture
Queensland Health
Moodys
McKesson
Harvard Business School
Novartis
McKinsey
Johnson and Johnson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Floxuridine - Generic Drug Details

« Back to Dashboard

What are the generic sources for floxuridine and what is the scope of floxuridine patent protection?

Floxuridine
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Pharmaforce, West-ward Pharms Int, and Hospira, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for floxuridine. One supplier is listed for this compound.
Pharmacology for floxuridine
Ingredient-typeDeoxyuridine
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for floxuridine

US Patents and Regulatory Information for floxuridine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int FLOXURIDINE floxuridine INJECTABLE;INJECTION 075387-001 Apr 16, 2000 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa FLOXURIDINE floxuridine INJECTABLE;INJECTION 075837-001 Feb 22, 2001 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira FUDR floxuridine INJECTABLE;INJECTION 016929-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmaforce FLOXURIDINE floxuridine INJECTABLE;INJECTION 203008-001 Nov 22, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Baxter
Argus Health
Fuji
Julphar
Cerilliant
US Department of Justice
Queensland Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot